Human mesenchymal stem cells and their use in cell-based therapies

Cancer

Volumn 116, Issue 11, 2010, Pages 2519-2530

  Motaln, Helena ^a,b   Schichor, Cristian ^c   Lah, Tamara T ^a,b  

^a NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cancer treatment; Cell based therapy; Human mesenchymal stem cells; Spontaneous transformation; Transformed mesenchymal stem cells

Indexed keywords

CYTOKINE; LENTIVIRUS VECTOR; PROTEIN TYROSINE KINASE; TELOMERASE REVERSE TRANSCRIPTASE;

CARCINOGENESIS; CELL AGING; CELL BASED GENE THERAPY; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; DNA MODIFICATION; HUMAN; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL EXPANSION; SUICIDE GENE THERAPY;

CELL AGING; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DNA FINGERPRINTING; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; NEOPLASMS; STEM CELL TRANSPLANTATION; TISSUE THERAPY;

EID: 77952805220     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25056     Document Type: Review

References (91)

1. Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia teleangiectasia patient. PLOS Med. 2009;6: e1000029.
2. Lee OK, Kuo TK, Chen W, Lee K, Hsieh S, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 2004;103:1669-1675. (Pubitemid 38268958)
3. Gang EJ, Jeong JA, Hong SH, et al. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells. 2004;22:617-624. (Pubitemid 39014577)
4. Ricci-Vitiani L, Pallini R, Larocca LM, et al. Mesenchymal differentiation of glioblastoma stem cells. Cell Death Differ. 2008;15:1491-1498.
5. Rebelatto CK, Aguiar AM, Moretao MP, et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood and adipose tissue. Exp Biol Med. 2008;233:901-913.
6. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24: 1294-1301. (Pubitemid 44464698)
7. Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22:625-634. (Pubitemid 39014578)
8. Alviano F, Fossati V, Marchionni C, et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol. 2007;1:11.
9. Gordon SL, Oppenheimer SR, Mackay AM, Brunnabend J, Puhlev I, Levine F. Recovery of human mesenchymal stem cells following dehydration and rehydration. Cryobiology. 2001;43:182-187. (Pubitemid 33780256)
10. Kogler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004;200:123-135.
11. Bernardo ME, Zaffaroni N, Novara F, et al. Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 2007;67:9142-9149. (Pubitemid 47535900)
12. Wagner W, Horn P, Castoldi M, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One. 2008;3:e2213.
13. Ito K, Aoyama T, Fukiage K, et al. A novel method to isolate mesenchymal stem cells from bone marrow in a closed system using a device made by nonwoven fabric. Tissue Eng Part C Methods. 2010;16:81-91.
14. Grayson LW, Zhao F, Bunnel B, Ma T. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun. 2007;358:948-953. (Pubitemid 46802482)
15. Thomas RJ, Hourd PC, Williams DJ. Application of process quality engineering techniques. J Biotechnol. 2008;136: 148-155.
16. Mishra PJ, Glod JW, Banerjee D. Mesenchymal stem cells: flip side of the coin. Cancer Res. 2009;69:1255-1258.
17. Rentsch B, Hofmann A, Breier A, et al. Embroidered and surface modified polycaprolactone-co-lactide scaffolds as bone substitute. Ann Biomed Eng. 2009;37:2118-2128.
18. Sotiropoulou PA, Perez AS, Salagianni M, Baxevanis CB, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24:462-471. (Pubitemid 44464816)
19. Birnbaum T, Roider J, Schankin CJ, et al. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol. 2007;83:241-247. (Pubitemid 46952234)
20. Qiu W, Andersen TE, Bollerslev J, Mandrup S, Abdallah BM, Kassem M. Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J Bone Miner Res. 2007;22:1720-1731. (Pubitemid 351235138)
21. Sawada R, Ito T, Tsuchiya T. Changes in expression of genes related to cell proliferation in human mesenchymal stem cells during in vitro culture in comparison with cancer cells. J Artif Organs. 2006;9:179-184. (Pubitemid 44453868)
22. Dominici M, LeBlanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy Position Statement. Cytotherapy. 2006;8:315-317.
23. Rubio D, Garcia-Castro J, Martin MC, et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005;65: 3035-3039. (Pubitemid 40524580)
24. Wang Y, Huso DL, Harrington J, et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy. 2005;7:509-519. (Pubitemid 43078081)
25. Kogler G, Radke FT, Lefort A, et al. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol. 2006;33:573-583. (Pubitemid 40592174)
26. Zannetino AC, Paton S, Arthur A, et al. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol. 2008; 214:413-421. (Pubitemid 350308998)
27. Nasef A, Zhang YZ, Mazurier C, et al. Selected Stro-1- enriched stromal cells display a major suppressive effect on lymphocyte proliferation. Int J Lab Hematol. 2009;31:9-19.
28. Otsuki S, Grogan SP, Miyaki S, et al. Tissue neogenesis and STRO-1 expression in mature and immature articular cartilage. J Orthop Res. 2010;28:96-102.
29. Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO, Wall DA. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat and neuronal markers. Biol Blood Marrow Transplant. 2007; 7:581-588.
30. Derfoul A, Miyoshi AD, Freeman DE, Tuan RS. Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthritis Cartilage. 2007;15:646-655. (Pubitemid 46778218)
31. Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine. 2005;32:270-279. (Pubitemid 43176649)
32. Izadpanah R, Kaushal D, Kriedt C, et al. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res. 2008;68:4229-4238.
33. Coipeau P, Rosset P, Langonne A, et al. Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients. Cytotherapy. 2009;22:1-11.
34. Moioli EK, Hong L, Guardado J, Clark PA, Mao JJ. Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells. Tissue Eng. 2006;12:537-546. (Pubitemid 43673459)
35. Bonora-Centelles A, Jover R, Mirabet V, et al. Sequential hepatogenic trans-differentiation of adipose tissue-derived stem cells: relevance of different extracellular signaling molecules, transcription factors involved and expression of new key marker genes. Cell Transplant. 2009;18:1319-1340.
36. Ong SY, Dai H, Leong KW. Hepatic differentiation potential of commercially available human mesenchymal stem cells. Tissue Eng. 2006;12:3477-3485. (Pubitemid 46037170)
37. Volkmer E, Kallkalam BC, Maertz J, et al. Hypoxic preconditioning of hMSC overcomes hypoxia-induced inhibition of osteogenic differentiation. Tissue Eng Part A. 2010;16:153-164.
38. Myllymaa S, Kaivosoja E, Myllymaa K, et al. Adhesion, spreading and osteogenic differentiation of mesenchymal stem cells cultured on micropatterned amorphous diamond, titanium, tantalum and chromium coatings on silicon. J Mater Sci Mater Med. 2010;21:329-341.
39. Kikuchi K, Fukuda M, Ito T, et al. Transcripts of unknown function in multiple-signalling pathways involved in human stem cell differentiation. Nucleic Acids Res. 2009;37:4987-5000.
40. Liedert A, Kassem M, Claes L, Ignatius A. Mechanosensitive promoter region in the human HB-GAM gene. Biochem Biophys Res Commun. 2009;387:289-293.
41. Genovese JA, Spadaccio C, Rivello HG, et al. Electrostimulated bone marrow human mesenchymal stem cells produce follistatin. Cytotherapy. 2009;11:448-456.
42. Lepperdinger G, Brunauer R, Jamnig A, Laschober G, Kassem M. Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies? Exp Gerontol. 2008; 43:1018-1023.
43. Potapova IA, Brink PR, Cohen IS, Doronin SV. Culturing of human mesenchymal stem cells as 3-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem. 2008;283:13100-13107.
44. Rubio D, Garcia S, Paz MF, et al. Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS One. 2008;3:e1398. (Pubitemid 351194017)
45. Rubio D, Garcia S, De la Cueva T, et al. Human mesenchymal stem cell transformation is associated with a mesenchymal- epithelial transition. Exp Cell Res. 2007;314:691-698.
46. Kidd S, Spaeth E, Dembinski JL, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescence imaging. Stem Cells. 2009;27:2614-2623.
47. Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA. 200;97:12846-12851.
48. Nakamizo A, Marini F, Amano T, et al. Human bone marrow- derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2006;65:3307-3318.
49. Schichor C, Birnbaum T, Etminan N, et al. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol. 2006;199:301-310. (Pubitemid 44202456)
50. Potapova IA, Cohen IS, Doronin SV. Apoptotic endothelial cells demonstrate increased adhesiveness for human mesenchymal stem cells. J Cell Physiol. 2009;219:23-30.
51. Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P. MMP-2, MT1-MMP and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflamatory cytokines. Blood. 2007;109: 4055-4063. (Pubitemid 46641761)
52. Lee BC, Hsu HC, Tseng WY, et al. Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits. Eur J Heart Fail. 2009;3: 238-245.
53. Hou X, Wu X, Ma J, Lv X, Jin X. Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia. Mol Biol Rep. 2010;37:1467-1475.
54. Plotnikov AN, Shlapakova I, Szabolcs MJ, et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation. 2007;116:706-713. (Pubitemid 47255987)
55. Denielyan L, Schafer T, Schulz A, et al. Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: the critical role of Epo. Cell Death Differ. 2009;16:1599-1614.
56. Figliuzzi M, Cornolti R, Perico N, et al. Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. Transplant Proc. 2009;41:1797-1800.
57. Qiao L, Xu Z, Zhao Z, et al. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res. 2008;18:500-507. (Pubitemid 351498857)
58. Li H, Fan X, Kovi RC, et al. Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res. 2007;67:10889-10898. (Pubitemid 350145918)
59. Burns JS, Abdallah BM, Guldberg P, Rygaard J, Schroder HD, Kassem M. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res. 2005;65: 3126-3135. (Pubitemid 40524593)
60. Matushansky I, Hernando E, Socci ND, et al. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clinic Invest. 2007;117:3248-3257. (Pubitemid 350096982)
61. Sawada R, Ito T, Tsuchiya T. Safety evaluation of tissue engineered medical devices using normal human mesenchymal stem cells. Yahugaku Zasshi. 2007;127:851-856. (Pubitemid 46684733)
62. Bocker W, Yin Z, Drosse I, et al. Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med. 2008; 12:1347-1359.
63. Stoff-Khalili MA, Rivera AA, Mathis JM, et al. Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat. 2007;105:157-167.
64. Sonabend AM, Ulasov IV, Tyler MA, Rivera AA, Mathis JM, Lesniak MS. Mesenchymal stem cells affectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells. 2008;26:831-841.
65. Mathis JM, Williams BJ, Sibley DA, et al. Cancer specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control. J Gene Med. 2006;8:1105-1120. (Pubitemid 44480403)
66. Dumont RJ, Dayoub H, Li JZ, et al. Ex vivo bone morphogenetic protein-9 therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery. 2002; 51:1239-1244. (Pubitemid 36322710)
67. Habisch HJ, Janowski M, Binder D, et al. Intrathecal application of neuroectodermally converted stem cells into mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm. 2007; 114:1395-1406.
68. Sumanasinghe RJ, Osborne JA, Loboa EG. Mesenchymal stem cell-seeded collagen matrices for bone repair. J Biomed Mater Res A. 2009;88:778-786.
69. Schneider OD, Loher S, Brunner TJ, et al. Cotton wool-like nanocomposite biomaterials prepared by electrospinning: in vitro bioactivity and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res B Appl Biomater. 2008;84:350-362.
70. Li C, Vepari C, Jin HJ, Kim HJ, Kaplan DL. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials. 2006;27:3115-3124. (Pubitemid 43247585)
71. Hsieh SC, Wang FF, Hung SC, Ceng YJ, Wang YJ. The internalized CdSe/ZnS quantum dots impair the chondrogenesis of bone marrow mesenchymal stem cells. J Biomed Mater Res B Appl Biomater. 2006;78:95-101. (Pubitemid 44477479)
72. Hsiao JK, Tsai CP, Chung TH, et al. Mesoporous silica nanoparticles as delivery system of gadolinium for effective human stem cell tracking. Small. 2008;4:1445-1452.
73. Babic M, Horak, Trchova M, et al. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labelling. Bioconjug Chem. 2008;19:740-750. (Pubitemid 351431406)
74. Shah B, Clark PA, Moioli EK, Stroscio MA, Mao JJ. Labeling of mesenchymal stem cells by bioconjugated quantum dots. Nano lett. 2007;7:3071-3079. (Pubitemid 350132932)
75. Henning TD, Sutton EJ, Kim A, et al. The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells. Contrast Media Mol Imaging. 2009;4:165-173.
76. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129:163-173.
77. Roobrouck VD, Ulloa-Montoya J, Verfaille CM. Sel-frenewal and differentiation capacity of young and aged stem cells. Exp Cell Res. 2008;314:1937-1944.
78. El-Badri NS, Hakki A, Ferrari A, Shamekh R, Good RA. Autoimmune disease: is it a disorder of the microenvironment? Immunol Res. 2008;41:79-86.
79. Karlsson C, Lindahl A. Articular cartilage stem cell signalling. Arthritis Res Ther. 2009;11:121.
80. Montjovent MO, Bocelli-Tyndall C, Scaletta C, et al. In vitro characterization of immune-related properties of human fetal bone cells for potential tissue engineering applications. Tissue Eng Part A. 2009;15:1523-1532.
81. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2004; 105:1815-1822. (Pubitemid 40223708)
82. Abdalah BM, Boissy P, Tan Q, et al. Dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors. J Biol Chem. 2007;282:7339-7351. (Pubitemid 47093687)
83. Sundin M, Barrett AJ, Ringden O, et al. HSCT recipients have specific tolerance to MSC but not to the MSC donor. J Immunother. 2009;32:755-764.
84. Ding HF, Liu R, Li BG, Lou JR, Dai KR, Tang TT. Biologic effect and immunoisolating behavior of BMP-2 gene-transfected bone marrow-derived mesenchymal stem cells in APA microcapsules. Biochem Biophys Res Commun. 2007; 362:923-927. (Pubitemid 47390662)
85. Tatsumi K, Otani H, Sato D, et al. Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation. Circ J. 2008;72:1351-1358.
86. Behr L, Hekmati M, Lucchini A, et al. Evaluation of the effect of autologous mesenchymal stem cell injection in a large-animal model. Cell Prolif. 2009;42:284-297.
87. Horwitz EM, Gordon PL, Koo WK. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A. 2002;99:8932-8937.
88. Le Blanc K, Rasmusson I, Sundberg B. Treatment of severe acute graft-versus-host-disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439-1441. (Pubitemid 38586721)
89. Le Blanc K, Gotherstrom C, Ringden O. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation. 2005;79:1607-1614. (Pubitemid 40847594)
90. Chen SL, Fang VW, Ye F. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Am J Cardiol. 2004;94:92-95. (Pubitemid 38813459)
91. Mazzini L, Fagioli F, Boccaletti R. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:158-161. (Pubitemid 37184884)